 |
市場調查報告書
商品編碼
1424485
全球生物影像市場：依影像方式、最終用戶、地區分類Global Bio-imaging Market, By Imaging Modality (Magnetic Resonance Imaging, Computed Tomography, Position Emission Tomography, Ultrasound, X-ray, Others), By End User, By Geography |
||||||
全球生物成像市場規模預計將從 2023 年的 57.4 億美元增至 2030 年的 155.8 億美元，預測期內複合年成長率為 15.3%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年 | 2022年 | 2023/2024年市場規模 | 57.4億美元 |
| 實際資料 | 2017-2021 | 預測期 | 2023-2030 |
| 2023/2024-2030/2031預測期複合年成長率 | 15.30% | 2030/2031價值預測 | 155.8億美元 |
生物成像是廣泛應用於生物學和醫學領域的強大而重要的技術。它是指獲取、處理和可視化生物系統從分子層次到器官層次的結構和功能資訊的技術集合。生物影像的主要目標是更深入地了解複雜的生物過程，促進準確的醫學診斷，並指南介入和治療。透過利用 X光、磁振造影(MRI)、正子斷層掃描 (PET)、超音波和光學顯微鏡等多種技術，生物成像為了解生物體的內部結構提供了一個非侵入性的窗口。它使研究人員和臨床醫生能夠即時觀察細胞和組織內複雜的相互作用，使其成為現代診斷和疾病機制研究的基石。最近的進展已將生物成像的前沿擴展到奈米尺度，使得即時追蹤細胞和分子事件成為可能。超高解析度顯微鏡、光聲成像和生物發光等技術正在揭示前所未有的細節，加深我們對涉及健康和疾病的生物途徑的理解。生物成像從根本上來說是跨學科的，涵蓋物理學、工程學、生物學、化學、電腦科學和醫學。它需要整合高解析度成像設備、複雜的影像分析軟體以及對潛在生物過程的深入了解。作為一種應用，生物成像在實驗室和醫療環境中至關重要。它有助於早期發現疾病，提高外科手術的精確度，並有助於開發標靶藥物治療。隨著生物成像成像技術的不斷發展，它有望透過考慮每個患者的生物組成的客製化治療方法來徹底改變個人化醫療。因此，生物成像處於科學進步的最前沿，彌合了基礎研究和臨床應用之間的差距，並推動了醫學創新的未來。
市場動態：
由於老年人口增加、慢性病和文明病盛行率增加、診斷成像方式的技術進步以及醫療保健支出增加等多種因素，預計全球生物成像市場在預測期內將出現強勁成長。然而，與生物成像系統、程序和放射示踪劑相關的高成本仍然是一個重大挑戰。此外，一些有關輻射暴露的指導方針和法規也抑制因素了市場。儘管如此，新興國家開拓的商機可能在不久的將來為市場相關人員開闢新的途徑。
本研究的主要特點
- 本報告對全球生物成像市場進行了詳細分析，並給出了以2023年為基準年的預測期（2023-2030年）的市場規模和年複合成長率（CAGR%）。
- 它還揭示了各個細分市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
- 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
- 它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球生物成像市場的主要企業。
- 該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
- 全球生物成像市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進入者和財務分析師。
- 透過用於分析全球生物成像市場的各種策略矩陣，將促進相關人員的決策。
目錄
第1章 研究目的與前提
- 研究目標
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章市場動態、法規及趨勢分析
- 市場動態
- 促進因素
- 生物成像模式的技術進步
- 抑制因素
- 需要大量資金投入
- 機會
- 混合成像系統
- 監管場景
- PEST分析
- 波特的分析
- 合併、收購和合作
第4章全球生物影像市場 -冠狀病毒(COVID-19) 大流行的影響
- 新型冠狀病毒感染疾病（COVID-19）的流行病學
- 供需面分析
- 經濟影響
第5章 全球生物影像市場（依影像方式），2018-2030 年
- 介紹
- 磁振造影(MRI)
- 電腦斷層掃描 (CT)
- 位置發射斷層掃描 (PET)
- 超音波
- X光
- 其他
第6章 全球生物影像市場，依最終使用者分類，2018-2030 年
- 介紹
- 醫院和診斷中心
- 學術研究所
- 製藥和生物技術公司
- 其他
第7章 全球生物影像市場（按地區），2018-2030
- 介紹
- 北美洲
- 美國
- 加拿大
- 歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 歐洲其他地區
- 亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- 東南亞國協
- 其他亞太地區
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
- 中東
- 海灣合作理事會國家
- 以色列
- 其他中東地區
- 非洲
- 南非
- 中部非洲
- 北非
第8章 競爭形勢
- 公司簡介
- Bracco Imaging SPA
- Bayer HealthCare Pharmaceuticals
- Esaote SpA
- Digirad Corporation
- FONAR Corporation
- GE Healthcare
- Hologic Inc
- Hitachi Medical Corporation
- Lantheus Medical Imaging, Inc.
- Covidien Pharmaceuticals
- Mindray Medical International Limited.
- Gamma Medica Inc
- Samsung Medison Co., Ltd.
- Philips Healthcare
第9章 章節
- 參考
- 調查方法
- 關於出版商
Global bio-imaging market size is expected to reach US$ 15.58 Bn by 2030, from US$ 5.74 Bn in 2023, exhibiting a compound annual growth rate (CAGR) of 15.3% during the forecast period.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2022 | Market Size in 2023/2024: | US$ 5.74 Bn |
| Historical Data for: | 2017 to 2021 | Forecast Period: | 2023 - 2030 |
| Forecast Period 2023/2024 to 2030/2031 CAGR: | 15.30% | 2030/2031 Value Projection: | US$ 15.58 Bn |
Bio-imaging is a powerful and essential technique that is widely used in the realm of biological and medical sciences. It refers to the ensemble of technologies that capture, process, and visualize structural and functional information of biological systems, ranging from the molecular to the organ level. The primary goal of bio-imaging is to gain a deeper understanding of complex biological processes, facilitate accurate medical diagnoses, and guide interventions and therapies. By leveraging diverse technologies such as X-ray, magnetic resonance imaging (MRI), positron emission tomography (PET), ultrasound, and optical microscopy, bio-imaging provides a non-invasive window into the inner workings of living organisms. It allows researchers and clinicians to observe the intricate interactions within cells and tissues in real-time, thereby making it a cornerstone in modern diagnostics and research on disease mechanisms. Recent advancements have expanded the frontiers of bio-imaging to nano-scale dimensions and have enabled real-time tracking of cellular and molecular events. Techniques such as super-resolution microscopy, photo acoustic imaging, and bioluminescence have brought unprecedented details to light, deepening our comprehension of biological pathways involved in health and disease. Fundamentally interdisciplinary, bio-imaging encompasses physics, engineering, biology, chemistry, computer science, and medicine. It demands the integration of high-resolution imaging instruments, sophisticated software for image analysis, and a profound knowledge of the underlying biological processes. In terms of its applications, bio-imaging is indispensable in research laboratories and healthcare settings. It aids in the early detection of diseases, enhances the precision of surgical procedures, and contributes to the development of targeted drug therapies. As bio-imaging technology continues to evolve, it promises to revolutionize personalized medicine by enabling a tailored approach to treatment that considers the unique biological makeup of each patient. Thus, bio-imaging stands at the forefront of scientific progress, bridging the gap between basic research and clinical application, and driving the future of healthcare innovations.
Market Dynamics:
Global bio-imaging market is expected to witness robust growth over the forecast period, due to several factors such as rising geriatric population, increasing incidence of chronic and lifestyle diseases, technological advancements in imaging modalities, and growing healthcare expenditure. However, high costs that are associated with bio-imaging systems, procedures, and radiotracers remain a major challenge. Several guidelines and regulations pertaining to radiation exposure also act as a restraint for the market. Nevertheless, untapped opportunities in emerging economies are likely to create new avenues for market players in the near future.
Key features of the study:
- This report provides an in-depth analysis of the global bio-imaging market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2023 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global bio-imaging market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Bracco Imaging S.P.A, Bayer HealthCare Pharmaceuticals, Esaote S.p.A, Digirad Corporation, FONAR Corporation, GE Healthcare, Hologic Inc, Hitachi Medical Corporation, Lantheus Medical Imaging, Inc., Covidien Pharmaceuticals, Mindray Medical International Limited., Gamma Medica Inc, Samsung Medison Co., Ltd., and Philips Healthcare.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global bio-imaging market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analysing the global bio-imaging market
Detailed Segmentation:
- Global Bio-imaging Market Segmentation, By Imaging Modality:
- Magnetic Resonance Imaging (MRI)
- Computed Tomography (CT)
- Position Emission Tomography (PET)
- Ultrasound
- X-ray
- Others
- Global Bio-imaging Market Segmentation, By End User:
- Hospitals & diagnostic centers
- Academic & research institutes
- Pharmaceutical & biotech companies
- Others
- Global Bio-imaging Market Segmentation, By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
- Top Companies in Global Bio-imaging Market:
- Bracco Imaging S.P.A
- Bayer HealthCare Pharmaceuticals
- Esaote S.p.A
- Digirad Corporation
- FONAR Corporation
- GE Healthcare
- Hologic Inc
- Hitachi Medical Corporation
- Lantheus Medical Imaging, Inc.
- Covidien Pharmaceuticals
- Mindray Medical International Limited.
- Gamma Medica Inc
- Samsung Medison Co., Ltd.
- Philips Healthcare
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Bio-imaging, By Imaging Modality
- Market Bio-imaging, By End User
- Market Bio-imaging, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Technological advancements in bio-imaging modalities
- Restraints
- High capital investment requirements
- Opportunities
- Hybrid imaging systems
- Key Highlights
- Regulatory Scenario
- Recent Trends
- PEST Analysis
- PORTER's Analysis
- Mergers, Acquisitions, and Collaborations
4. Global Bio-imaging Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Bio-imaging Market, By Imaging Modality, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Magnetic Resonance Imaging (MRI)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Computed Tomography (CT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Position Emission Tomography (PET)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Ultrasound
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- X-ray
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
6. Global Bio-imaging Market, By End User, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Hospitals & diagnostic centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Academic & research institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Pharmaceutical & biotech companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
7. Global Bio-imaging Market, By Region, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2019 -2030
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
- South Africa
- Central Africa
- North Africa
8. Competitive Landscape
- Company Profile
- Bracco Imaging S.P.A
- Company Highlights
- Imaging Modality Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bayer HealthCare Pharmaceuticals
- Company Highlights
- Imaging Modality Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Esaote S.p.A
- Company Highlights
- Imaging Modality Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Digirad Corporation
- Company Highlights
- Imaging Modality Portfolio
- Key Highlights
- Financial Performance
- Strategies
- FONAR Corporation
- Company Highlights
- Imaging Modality Portfolio
- Key Highlights
- Financial Performance
- Strategies
- GE Healthcare
- Company Highlights
- Imaging Modality Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Hologic Inc
- Company Highlights
- Imaging Modality Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Hitachi Medical Corporation
- Company Highlights
- Imaging Modality Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Lantheus Medical Imaging, Inc.
- Company Highlights
- Imaging Modality Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Covidien Pharmaceuticals
- Company Highlights
- Imaging Modality Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Mindray Medical International Limited.
- Company Highlights
- Imaging Modality Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Gamma Medica Inc
- Company Highlights
- Imaging Modality Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Samsung Medison Co., Ltd.
- Company Highlights
- Imaging Modality Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Philips Healthcare
- Company Highlights
- Imaging Modality Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
9. Section
- References
- Research Methodology
- About us
